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Abstract 
Objective: The primary objective of this study was to assess whether Ohio community pharmacists currently provide certain evidence-
based clinical preventive services.  Secondary objectives were to explore whether there were any differences in provision of services 
based on respondent education, position, employment status, location, practice setting, or years in practice and to gather information 
on how pharmacists provide specific services, barriers to providing specific services, pharmacists’ perceptions on specific services 
needed in their patient population, and pharmacists’ interests in providing services if not already doing so. 
Methods:  A random sample of 500 community pharmacists licensed in Ohio received a Qualtrics survey via email assessing current 
practices and perspectives regarding clinical preventive services. The U.S. Preventive Services Task Force (USPSTF) “A” and “B” 
recommended services that can be provided in a community pharmacy served as the framework for the survey questions. Reminders 
were sent every 3-4 days; data collection continued for a month. The study was IRB-approved. 
Results: Ninety-three responses were included in the final analysis (18.9% response rate). Approximately 63% of respondents were 
female; 51.6% held a Doctor of Pharmacy degree. Only 21.5% of respondents were familiar with the USPSTF. However, many 
respondents were providing clinical preventive services in their pharmacy; the most common were blood pressure screening (51.6%), 
tobacco use screening or counseling (43%), and diet and/or physical activity counseling (22.6%).  These services were provided in varied 
ways including patient counseling, medication therapy management sessions, screening events, and health fairs.  Those who are not 
currently providing services showed interest in developing them.  Pharmacists reported barriers such as lack of time, staff, and 
reimbursement by patients or third-party payers. 
Conclusion:  Many surveyed community pharmacists in Ohio reported providing clinical preventive services in a variety of ways. Many 
pharmacists who did not provide these services indicated an interest developing such services.  Staffing concerns, time constraints, and 
a lack of reimbursement by patients and third-party payers were reported as barriers by community pharmacists in providing these 
services.  As many respondents reported being unfamiliar with USPSTF recommendations, the opportunity to educate pharmacist on 
these recommendations and potentially increase their activity in these prevention activities exists.   
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Introduction 
Clinical preventive services such as immunizations and routine 
disease screenings can decrease morbidity and mortality1.  
However, many adults in the United States (U.S.) do not 
receive necessary clinical preventive services.1,2  A recent study 
showed that as of 2015, only 8% of adults in the U.S. 35 years 
and older had received all recommended clinical preventive 
services. Close to 5% of U.S. adults did not receive any of the 
clinical preventive services recommended for them.2 
 
Community pharmacists have the knowledge and training to 
provide many clinical preventive services.3.4  The pharmacists’ 
advanced education and continuing professional development 
allows them to disseminate basic health advice to patients in 
the form of counseling. In addition, the community pharmacist 
often has access to tools and equipment to facilitate screening 
and monitoring for various disease states such as hypertension 
or Type 2 diabetes.   
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The accessibility of the community pharmacist also provides 
opportunities for delivery of these services to the public.  Most 
community pharmacists meet with patients without an 
appointment, and many pharmacies are open extended hours. 
It has been estimated that one-third to one-half of U.S. 
residents do not have a medical home; however, the average 
resident lives within 5 miles of a community pharmacy.5 In 
addition, vulnerable or hard-to-reach populations are often 
able to access a community pharmacy.6 Due to their 
availability and expertise, there is great potential for 
community pharmacists to provide clinical preventive services 
and close gaps in care.3,4   
 
Objectives 
The primary objective of this study was to assess whether Ohio 
community pharmacists currently provide certain evidence-
based clinical preventive services.  Secondary objectives were 
to explore whether there were any differences in provision of 
services based on respondent education, position, 
employment status, location, practice setting, or years in 
practice and to gather information on how pharmacists 
provide specific services, barriers to providing specific services, 
pharmacists’ perceptions on specific services needed in their 
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patient population, and pharmacists’ interests in providing 
services if not already doing so. 
 
Methods 
Setting and sample 
The State of Ohio Board of Pharmacy was contacted to obtain 
a list of all pharmacists currently registered in Ohio as of 
October 2017.  The list was narrowed to pharmacists with an 
e-mail address on-file who reported a community pharmacy in 
Ohio as their primary practice site. A random number 
generator was used to select 500 pharmacists from this list to 
receive the survey.   
 
Survey development and implementation 
A survey tool was developed to assess pharmacist provision of 
certain clinical preventive services.  To identify which services 
to include in the survey questions, the United States 
Preventive Service Task Force (USPSTF) “A” and “B” 
recommended services for the general, non-pregnant adult 
population were utilized as a framework. The USPSTF is a 
group of experts utilizing evidence-based medicine to make 
recommendations about clinical preventive services, excluding 
immunizations, that should be offered in primary care settings 
to different patient populations (general adult, pregnant 
women, or pediatric).7  The USPSTF grades the varied primary 
or secondary prevention services as “A-I” based on the 
available data regarding effectiveness, benefits, and harms. 
The USPSTF recommendations that are classified as “A” (high 
certainty of benefit) or “B” (high certainty of moderate benefit 
or moderate certainty that the benefit is moderate to 
substantial) should be routinely provided to all individuals 
within the defined patient population.  The USPSTF does not 
make specific recommendations regarding vaccinations but 
instead defers to the Centers for Disease Control and 
Prevention's (CDC) Advisory Committee on Immunization 
Practices (ACIP).7    Previous papers have highlighted which 
USPSTF “A” and “B” recommended services pharmacists may 
be especially suited to provide,3,4 and the list (Table 1) was 
limited to exclude a service that would require prescription of 
a medication (e.g., statin preventive medication) as it would be  
too difficult to capture via the survey tool whether the 
pharmacist initiated the service or simply dispensed the 
medication.  
 
Twenty-six questions were included in the survey tool.  
Thirteen questions captured respondent demographics, six 
questions assessed pharmacists’ provision of clinical 
preventive services, and seven questions captured opinions 
about the services.  The questions were distributed 
electronically via Qualtrics Labs (Provo, UT).   
 
Six pharmacists with experience in community pharmacy pilot-
tested the survey to assess face validity and check for any 
technical difficulties. The six pharmacists were not part of the 
sample.  Following completion of pilot testing, the survey was 
sent via email to the sample in November 2017. Reminder 
emails were sent every 3-4 days; data collection continued for 
one month. The surveys were completed anonymously, and no 
incentives were offered for survey participation.  The cover 
letter accompanying the survey did not explicitly state the 
focus of the survey questions.  The study was approved by the 
Ohio Northern University Institutional Review Board.  
 
Statistical analysis 
Descriptive statistics were analyzed with Microsoft Office Excel 
2013 (Redmond, WA) and analytic statistics were analyzed 
with IBM SPSS 22 (Armonk, NY) and Vassarstats 
(Poughkeepsie, NY). Chi-square or Fisher exact nonparametric 
statistical tests were used as appropriate to identify whether 
there were any significant differences in provision of clinical 
preventive services based on respondent education, position, 
employment status, location, practice setting, or years in 
practice.  Statistical significance was defined a priori as a p 
value of < 0.05. 
 
Results 
The survey was delivered to 491 pharmacists (9 emails were 
undeliverable).  Ninety-three pharmacists completed the 
survey for a response rate of 18.9%.  Table 2 displays the 
characteristics of the respondents.   
 
Sixty-five respondents (69.9%) reported providing at least one 
clinical preventive service in the community pharmacy       
(Table 3).  Of the 18 services community pharmacists may be 
able to provide, pharmacists reported 0-12 services provided 
at their location. The most common services provided were 
blood pressure screening (51.6%), tobacco use screening or 
counseling (43%), and diet and/or physical activity counseling 
(22.6%).  Ways in which pharmacists reported providing these 
services included individual patient counseling (36.6%); 
medication therapy management (MTM) sessions (34.4%); 
general education (posters in pharmacy, brochures, flyers, and 
other types of patient education materials) (33.3%); screening 
events (24.7%); health fairs (17.2%); stand-alone equipment in 
the pharmacy (i.e., blood pressure monitors) (5.4%); 
collaborative practice agreements (5.4%); and employer 
contracts (1.1%).  Those who are not currently providing 
clinical preventive services showed interest in developing such 
services (Table 4).   
 
Years in practice was statistically significantly associated with 
provision of at least 1 clinical preventive service (p=0.011), 
with pharmacists who more recently entered the profession 
reporting that they provided more services.  In addition, 
pharmacists who worked full-time were statistically 
significantly more likely to provide at least 1 service (p<0.001).  
Education, position, location, or practice setting were not 
associated with provision of services. 
 
When asked to identify the top five needs in their patient 
population from the list of clinical preventive services, 
community pharmacists selected type 2 diabetes screening 
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(81.7%), blood pressure screening (66.7%), tobacco use 
screening or counseling (63.4%), cholesterol screening (43%), 
and diet/physical activity counseling (37%).  The top five needs 
did not change based upon whether the pharmacist was in a 
rural, urban, or suburban location. 
 
Table 5 lists the barriers pharmacists reported to providing 
these services. The most common barriers were lack of time 
(79.6%), staff (65.6%), and reimbursement by patients or third-
party payers (55.9%). Of note, only 4% thought that the 
services were not needed in their patient populations. 
 
Eighty-five percent of respondents indicated wanting to learn 
more about at least one of the services discussed in the survey 
(Table 6).  When asked about preferred methods to receive 
this information, respondents most often selected web-based 
continuing education program (61.3%), followed by live 
continuing education program (33.3%), pharmacy journal 
(16.1%), and pharmacy conference (15.1%). 
 
Discussion 
Many stakeholders in the U.S. healthcare system are 
increasing their focus on preventive and primary care services.  
Community pharmacists in particular have great opportunity 
to improve patient outcomes through provision of clinical 
preventive services due to their accessible nature.8  The role of 
the community pharmacist has expanded to include 
comprehensive clinical services;9 over the last decade, 
pharmacists have reported spending more time on preventive 
care services such as immunizations and screenings and less 
time on medication dispensing.10 Pharmacists can also provide 
referrals for services not typically provided in a community 
pharmacy (e.g., cancer screenings).3,4 
 
This study found that nearly 70% of respondents provided at 
least one clinical preventive service. Previously published 
articles have detailed the experience of an ambulatory care 
pharmacist providing USPSTF recommendations to employees 
at part of a worksite wellness program11 and systematic 
reviews have examined community pharmacists’ provision of 
patient care services, including screening services.9,12,13  The 
findings of this study were consistent with the articles included 
in the systematic reviews. For example, the ways in which 
community pharmacists provided the screening service (walk-
in, health fair, counseling session) and the types of services 
provided (screenings for disease such as diabetes or 
cardiovascular disease) were similar.12,13  This survey assessed 
some topics not included in previous studies, such as 
behavioral counseling for skin cancer prevention. 
 
Three services (intimate partner violence screening, 
tuberculosis screening, and osteoporosis screening) were not 
reported as offered by any respondent.  It was surprising that 
no respondents reported that they conducted osteoporosis 
screenings, as this is a service that has been included in the 
published literature as occurring in community pharmacies in 
the U.S.13  In previous studies, pharmacists in Ohio have 
reported lack of training regarding intimate partner violence 
screening.14  Currently, tuberculosis screening is not a service 
routinely offered in Ohio community pharmacies. 
 
While the USPSTF “A” and “B” recommendations served as a 
framework to determine which clinical preventive services 
community pharmacists should be routinely offering to 
patients and therefore queried in the survey, whether 
pharmacists were following the recommendation was not 
assessed. As close to 79% of respondents reported being 
unfamiliar with USPSTF recommendations, it may be likely that 
community pharmacists are providing services but may not be 
following evidence-based practice in regards to identification 
of patients most likely to benefit from the service or 
appropriate screening intervals.  Therefore, there is a need to 
educate community pharmacists on the USPSTF 
recommendations through continuing pharmacy education.  
Additionally, pharmacists should be made aware of tools, such 
as the Electronic Preventive Services Selector, or ePSS, that can 
be utilized to identify which services each patient needs.15   As 
85% of respondents indicated through the survey that they 
wanted more information about the services, it seems 
pharmacists would be interested in such educational 
opportunities.  Educating community pharmacists on these 
recommendations could result in an increased recognition of 
the need and the desire to provide these services. 
 
Furthermore, many of those who currently did not provide 
services were interested in developing them.  Addressing the 
reported barriers, including reimbursement for community 
pharmacists to provide these services, will be essential in 
establishing new services and increasing capacity to impact 
their communities’ health.  Given the pharmacies’ extended 
hours and locations in rural areas that may otherwise lack 
primary care services, the development of these services can 
have important implications for improving population health. 
 
Limitations of this study include the response rate and possible 
response bias.  Results may not be generalizable to all Ohio 
community pharmacists or community pharmacists in other 
states.  The pharmacists’ scope of practice varies by state, and 
this could influence which services are routinely offered by 
pharmacists. While the cover letter accompanying the survey 
did not disclose the specific focus of the study, it is possible 
that those responding to the survey may have differed 
systemically than those who did not respond to the survey.  In 
addition, the survey tool utilized in the study was not a 
validated tool. 
 
There are several potential areas for future research.  This 
study focused on whether the pharmacist provided a 
particular service, but not to the level of detail of whether the 
services were being provided to patients as specified in the 
USPSTF recommendations; this is an area for further research. 
Future studies should also examine how many patients who 
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receive these services follow-up as needed.  Additional studies 
to determine best practices for community pharmacists to 
identify patients in their population most likely to benefit from 
these services should be performed.  Studies are also needed 
to determine how to integrate pharmacy-based services with 
services provided by other healthcare providers; incorporating 
community pharmacists into health information exchange may 
help to reduce the number of duplicative services and increase 
communication among all members of the healthcare team.  
Effectiveness and cost-effectiveness of performing these 
services in community pharmacies compared to other settings 
should also be explored.  Finally, patient satisfaction and 
receptivity to such services being provided in the community 
pharmacy should be studied.8,9,12,13   
 
Conclusion 
Many surveyed community pharmacists in Ohio reported 
providing clinical preventive services in a variety of ways. Many 
pharmacists who did not provide these services indicated an 
interest developing such services.  Staffing concerns, time 
constraints, and a lack of reimbursement by patients and third-
party payers were reported by community pharmacists as 
barriers in providing these services.  As many respondents 
reported being unfamiliar with USPSTF recommendations,     
the opportunity to educate pharmacists on these 
recommendations and potentially increase their activity in 
these prevention activities exists.  Additional studies are 
needed to quantify the impact of community pharmacist 
provision of clinical preventive services on patient outcomes. 
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Table 1. Clinical preventive services that community pharmacists may be able to provide3,4 
 
Alcohol misuse screening and counseling 
Blood pressure screening 
Breastfeeding counseling 
Cholesterol screening 
Depression screening 
Diabetes screening 
Fall prevention in older adults 
Counseling on folic acid supplementation to prevent birth defects 
Healthy diet and physical activity counseling 
Hepatitis C screening  
HIV screening 
Intimate partner violence screening 
Obesity screening and management 
Osteoporosis screening 
Sexually transmitted infection behavioral counseling 
Skin cancer behavior counseling 
Tobacco use counseling and interventions  
Tuberculosis screening 
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Table 2. Characteristics of survey respondents (n=93) 
 
Characteristic n (%) 
Gender 
      Male 
      Female 
      Prefer not to answer 
 
33 (35.5) 
59 (63.4) 
  1 (1.1) 
Education* 
      Bachelor of Science in Pharmacy 
      Doctor of Pharmacy 
      Residency 
 
50 (53.8) 
48 (51.6) 
  2 (2.2) 
Years in Practice 
       5 years or less 
       6-10 years 
      11-20 years 
      More than 20 years 
 
25 (26.9) 
19 (20.4) 
13 (14) 
36 (38.7) 
Position* 
      Staff pharmacist 
      Pharmacy manager 
      Clinical/MTM pharmacist 
 
52 (55.9) 
42 (45.2) 
11 (11.8) 
Employment status 
      Full-time 
      Part-time 
 
82 (88.2) 
11 (11.8) 
Location 
      Rural 
      Suburban 
      Urban 
 
23 (24.7) 
44 (47.3) 
26 (28) 
Practice Setting 
      Chain pharmacy (e.g., CVS, Walgreens, etc) 
      Grocery (e.g., Kroger, Giant Eagle, etc) 
      Mass merchandiser (ex: Walmart, Kmart, etc) 
      Independent pharmacy  
      Blank 
 
39 (41.9) 
26 (28) 
10 (10.8) 
16 (17.2) 
  2 (2.2) 
Familiar with USPSTF recommendations 
      Yes 
       No 
 
20 (21.5) 
73 (78.5) 
* Respondents could select >1 choice 
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Table 3. Respondents (n=93) offering clinical preventive services in the community pharmacy 
 
Clinical Preventive Service n (%)*  
Alcohol misuse screening or counseling   4 (4.3) 
Blood pressure screening 48 (51.6) 
Breastfeeding counseling   1 (1.1) 
Cholesterol screening 16 (17.2) 
Depression screening   2 (2.2) 
Diabetes screening 19 (20.4) 
Fall prevention in older adults 13 (14) 
Counseling on folic acid supplementation to prevent birth defects 19 (20.4) 
Healthy diet and/or physical activity counseling 21 (22.6) 
Hepatitis C screening    2 (2.2) 
HIV screening   2 (2.2) 
Intimate partner violence screening   0 (0) 
Obesity screening and management   7 (7.5) 
Osteoporosis screening   0 (0) 
Sexually transmitted infection behavioral counseling   5 (5.4) 
Skin cancer behavior counseling   9 (9.7) 
Tobacco use screening or counseling  40 (43) 
Tuberculosis screening   0 (0) 
* Note: Respondents could select >1 service 
 
 
 
Table 4. Respondents (n=93) not currently offering clinical preventive services  
in the community pharmacy but interested in doing so 
Clinical Preventive Service n (%)*  
Alcohol misuse screening or counseling   37 (39.8) 
Blood pressure screening   22 (23.7) 
Breastfeeding counseling   30 (32.3) 
Cholesterol screening   40 (43) 
Depression screening   27 (29) 
Diabetes screening   39 (41.9) 
Fall prevention in older adults   39 (41.9) 
Counseling on folic acid supplementation to prevent birth defects   34 (36.6) 
Healthy diet and/or physical activity counseling   31 (33.3) 
Hepatitis C screening    27 (29) 
HIV screening   24 (25.8) 
Intimate partner violence screening   22 (23.7) 
Obesity screening and management   34 (36.6) 
Osteoporosis screening   41 (44.1) 
Sexually transmitted infection behavioral counseling   31 (33.3) 
Skin cancer behavior counseling   36 (38.7) 
Tobacco use screening or counseling    38 (40.9) 
Tuberculosis screening   26 (28) 
* Note: Respondents could select >1 service 
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Table 5.  Barriers to providing clinical preventive services reported by community pharmacists (n=93) 
 
Barrier   n (%)*  
Lack of time 74 (79.6) 
Lack of staff 61 (65.6) 
Lack of reimbursement 52 (55.9) 
Don’t feel knowledgeable/don’t have skills to provide 48 (51.6) 
Lack of space 47 (50.5) 
Lack of required resources (CLIA waiver, supplies, etc) 35 (37.6) 
Patient not receptive 34 (36.6) 
Other healthcare professionals likely providing service 33 (35.5) 
Not needed in patient population   4 (4.3) 
* Note: Respondents could select >1 barrier 
 
 
 
 
Table 6.  Respondents (n=93) wanting more information about clinical preventive services 
 
Clinical Preventive Service n (%)*  
Alcohol misuse screening and counseling 27 (29) 
Blood pressure screening 36 (38.7) 
Breastfeeding counseling 19 (20.4) 
Cholesterol screening 33 (35.5) 
Depression screening 28 (30.1) 
Diabetes screening 31 (33.3) 
Fall prevention in older adults 18 (19.4) 
Counseling on folic acid supplementation to prevent birth defects 19 (20.4) 
Healthy diet and/or physical activity counseling 38 (40.9) 
Hepatitis C screening  15 (16.1) 
HIV screening 19 (20.4) 
Intimate partner violence screening 12 (12.9) 
Obesity screening and management 25 (26.9) 
Osteoporosis screening 23 (24.7) 
Sexually transmitted infection behavioral counseling 18 (19.4) 
Skin cancer behavior counseling 27 (29) 
Tobacco use screening and counseling 33 (35.5) 
Tuberculosis screening 13 (14) 
* Note: Respondents could select >1 service 
 
 
 
 
 
  
